Evidence map›Paper›PMID 34084166›Full record

ArticleFrontiers in immunology2021

CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.

Barbara Bassani, Claudio Tripodo, Paola Portararo, Alessandro Gulino, Laura Botti, Claudia Chiodoni, Elena Jachetti, Niccolò Bolli, Marilena Ciciarello, Korinna Joehrens and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Barbara BassaniDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Claudio TripodoUniversity of Palermo School of Medicine, Palermo, Italy.
Paola PortararoDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Alessandro GulinoUniversity of Palermo School of Medicine, Palermo, Italy.
Laura BottiDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Claudia ChiodoniDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Elena JachettiDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Niccolò BolliDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Marilena CiciarelloDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, Institute of Hematology "Seràgnoli", Bologna, Italy.
Korinna JoehrensCharité-Universitätsmedizin Berlin, Institute of Pathology, Berlin, Germany.
Ioannis AnagnostopoulosInstitute of Pathology, University of Wuerzburg, Wuerzburg, Germany.
Il-Kang NaDepartment of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin, Berlin, Germany.
Antonio CurtiDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, Institute of Hematology "Seràgnoli", Bologna, Italy.
Mario P ColomboDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Sabina SangalettiDepartment of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori · ITCharité - Universitätsmedizin Berlin · DEUniversity of Palermo · ITUniversity of Milan · ITUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Within the bone marrow (BM), mature T cells are maintained under homeostatic conditions to facilitate proper hematopoietic development. This homeostasis depends upon a peculiar elevated frequency of regulatory T cells (Tregs) and immune regulatory activities from BM-mesenchymal stem cells (BM-MSCs). In response to BM transplantation (BMT), the conditioning regimen exposes the BM to a dramatic induction of inflammatory cytokines and causes an unbalanced T-effector (Teff) and Treg ratio. This imbalance negatively impacts hematopoiesis, particularly in regard to B-cell lymphopoiesis that requires an intact cross-talk between BM-MSCs and Tregs. The mechanisms underlying the ability of BM-MSCs to restore Treg homeostasis and proper B-cell development are currently unknown. Methods: We studied the role of host radio-resistant cell-derived CD40 in restoring Teff/Treg homeostasis and proper B-cell development in a murine model of BMT. We characterized the host cellular source of CD40 and performed radiation chimera analyses by transplanting WT or Results: CD40 expression is nearly undetectable in the BM, yet a Conclusions: CD40+ BM-MSCs are immune regulatory elements within BM. Loss of CD40 results in uncontrolled T cell activation due to a reduced number of Tregs, and B-cell development is consequently impaired. GVHD provides an example of how a loss of CD40+ BM-MSCs and a reduction in B-cell precursors may occur in a human setting.

Indexed as

Bone Marrow TransplantationAdultAgedAnimalsBone MarrowBone Marrow CellsCD40 AntigensFemaleGene Expression RegulationHomeostasisHumansLymphocyte ActivationMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceCD40 AntigensOX40 LigandTNFSF4 protein, humanTnfsf4 protein, mouseB-cell developmentbone marrow transplantationCD40mesenchymal cellOX40L

Identifiers

PMID34084166
PMCPMC8168593
OpenAlexW3162194300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.